Home

Recent Articles from StockStory

StockStory is a financial technology company dedicated to simplifying profitable stock investing for individual investors. By leveraging advanced AI technology and human expertise, it generates detailed, data-driven research reports and monthly stock picks to identify high-quality stocks with strong growth potential. The company aims to democratize access to sophisticated analytical methods and proprietary datasets—previously exclusive to elite hedge funds—delivering clear, actionable insights rather than complex, do-it-yourself tools. With a mission to level the playing field in a market often favoring large institutions, StockStory provides retail investors with the resources to make informed, market-beating investment decisions.

Zeta’s (NYSE:ZETA) Q1 Sales Beat Estimates
Advertising and marketing company Zeta Global (NYSE:ZETA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 35.6% year on year to $264.4 million. The company expects next quarter’s revenue to be around $296.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
CLOV Q1 Earnings Call: Membership Growth and Technology Drive Profitability Above Expectations
Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 33.3% year on year to $462.3 million. Its non-GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
FBIN Q1 Earnings Call: Tariff Pressures and Demand Uncertainty Weigh on Results
Home and security products company Fortune Brands (NYSE:FBIN) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 6.9% year on year to $1.03 billion. Its non-GAAP profit of $0.66 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
MASI Q1 Earnings Call: Revenue Tops Expectations, Focus Shifts to Healthcare Core Amid Tariff Headwinds
Medical tech company Masimo (NASDAQ:MASI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $372 million. The company expects the full year’s revenue to be around $1.52 billion, close to analysts’ estimates. Its non-GAAP profit of $1.36 per share was 12.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
SRPT Q1 Earnings Call: Sarepta Adjusts Guidance After Safety Event and Administrative Delays
Biotech company Sarepta Therapeutics (NASDAQ:SRPT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 80.2% year on year to $744.9 million. Its non-GAAP loss of $3.42 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
PNTG Q1 Earnings Call: Acquisition Momentum and Organic Growth Drive Outperformance
Senior living provider The Pennant Group (NASDAQ:PNTG) announced better-than-expected revenue in Q1 CY2025, with sales up 33.7% year on year to $209.8 million. Its non-GAAP profit of $0.27 per share was 13.7% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
LOPE Q1 Earnings Call: New Program Growth and Hybrid Enrollment Drive Guidance Update
Higher education company Grand Canyon Education (NASDAQ:LOPE) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.3% year on year to $289.3 million. The company expects next quarter’s revenue to be around $240.3 million, close to analysts’ estimates. Its GAAP profit of $2.52 per share was 2.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MYGN Q1 Earnings Call: Guidance Cut Amid GeneSight Challenges and Slow Hereditary Cancer Ramp
Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 3.1% year on year to $195.9 million. The company’s full-year revenue guidance of $815 million at the midpoint came in 3.7% below analysts’ estimates. Its non-GAAP loss of $0.03 per share was $0.02 above analysts’ consensus estimates.
Via StockStory · May 19, 2025
FLYW Q1 Earnings Call: Revenue Beats, Margin Pressures, and Expansion in Education and Travel
Cross border payment processor Flywire (NASDAQ: FLYW) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 17% year on year to $133.5 million. The company expects next quarter’s revenue to be around $124.4 million, close to analysts’ estimates. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
JAZZ Q1 Earnings Call: Revenue and Profit Miss, Product Pipeline Drives Outlook
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $897.8 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.28 billion at the midpoint. Its non-GAAP profit of $1.68 per share was 63.9% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
NATR Q1 Earnings Call: Outperformance Driven by Asia-Pacific and Europe Amid Tariff Uncertainty
Wellness products company Nature’s Sunshine (NASDAQ:NATR) announced better-than-expected revenue in Q1 CY2025, with sales up 2% year on year to $113.2 million. The company expects the full year’s revenue to be around $457.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.25 per share was 51.5% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
OPEN Q1 Earnings Call: Asset-Light Expansion and Cost Discipline Amid Housing Headwinds
Technology real estate company Opendoor (NASDAQ:OPEN) announced better-than-expected revenue in Q1 CY2025, but sales fell by 2.4% year on year to $1.15 billion. On the other hand, next quarter’s revenue guidance of $1.49 billion was less impressive, coming in 0.8% below analysts’ estimates. Its non-GAAP loss of $0.09 per share was 15.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
VRNS Q1 Earnings Call: SaaS Transition Drives Outperformance and Raises Profit Outlook
Data protection and security software company Varonis (NASDAQ:VRNS) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 19.6% year on year to $136.4 million. The company expects next quarter’s revenue to be around $147.5 million, close to analysts’ estimates. Its non-GAAP profit of $0 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
REZI Q1 Earnings Call: Pricing Actions and Tariff Mitigation Drive Outperformance
Home automation and security solutions provider Resideo Technologies (NYSE:REZI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 19.1% year on year to $1.77 billion. The company expects next quarter’s revenue to be around $1.83 billion, close to analysts’ estimates. Its non-GAAP profit of $0.63 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
SWIM Q1 Earnings Call: Latham Focuses on Sand States Expansion and Operational Efficiency
Residential swimming pool manufacturer Latham (NASDAQ:SWIM) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $111.4 million. The company’s full-year revenue guidance of $550 million at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP loss of $0.04 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
AZEK Q1 Earnings Call: Outperformance Driven by Material Conversion and Strategic Merger Plans
Outdoor living products manufacturer AZEK Company (NYSE:AZEK) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.1% year on year to $452.2 million. On the other hand, the company’s full-year revenue guidance of $1.54 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.45 per share was 3.1% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MTW Q1 Earnings Call: Tariff Pressures, Order Momentum, and Aftermarket Strategy in Focus
Crane and lifting equipment company Manitowoc (NYSE:MTW) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.9% year on year to $470.9 million. Its non-GAAP loss of $0.16 per share was 72.7% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
TDC Q1 Earnings Call: Revenue Miss and Cautious Services Outlook Offset by Margin Expansion
Data and analytics software provider Teradata (NYSE:TDC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 10.1% year on year to $418 million. Next quarter’s revenue guidance of $401.1 million underwhelmed, coming in 1.4% below analysts’ estimates. Its non-GAAP profit of $0.66 per share was 16.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
PRPL Q1 Earnings Call: Wholesale Expansion and Margin Gains Amid Industry Headwinds
Bedding and comfort retailer Purple (NASDAQ:PRPL) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 13.2% year on year to $104.2 million. The company’s full-year revenue guidance of $475 million at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP loss of $0.11 per share was 23.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
UPST Q1 Earnings Call: Revenue Beat Led by AI Model Gains, Guidance Edges Higher
AI-powered lending platform Upstart (NASDAQ:UPST) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 67% year on year to $213.4 million. On the other hand, next quarter’s revenue guidance of $225 million was less impressive, coming in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.30 per share was 76.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
QLYS Q1 Earnings Call: Channel Partnerships and AI Security Drive Outperformance
Cloud security and compliance software provider Qualys (NASDAQ:QLYS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.7% year on year to $159.9 million. The company expects next quarter’s revenue to be around $161.2 million, close to analysts’ estimates. Its non-GAAP profit of $1.67 per share was 13.8% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
RVLV Q1 Earnings Call: Management Details Tariff Mitigation and Brand Investments Amid Macro Uncertainty
Online fashion retailer Revolve (NASDAQ:RVLV) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.7% year on year to $296.7 million. Its non-GAAP profit of $0.16 per share was 7.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
WYNN Q1 Earnings Call: Tariff Delays, Cost Controls, and Market Dynamics Shape Outlook
Luxury hotels and casino operator Wynn Resorts (NASDAQ:WYNN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 8.7% year on year to $1.7 billion. Its non-GAAP profit of $1.07 per share was 14% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
GO Q1 Earnings Call: Management Cites Execution Initiatives Amid Flat Same-Store Sales
Discount grocery store chain Grocery Outlet (NASDAQ:GO) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.5% year on year to $1.13 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.75 billion at the midpoint. Its non-GAAP profit of $0.13 per share was 87.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MRCY Q1 Earnings Call: Revenue Beat Expectations, Margins and Cash Flow Improve Amid Backlog Transition
Aerospace and defense company Mercury Systems (NASDAQ:MRCY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 1.5% year on year to $211.4 million. Its non-GAAP profit of $0.06 per share was $0.01 below analysts’ consensus estimates.
Via StockStory · May 19, 2025
WW Q4 Earnings Call: Product Integration, Subscriber Challenges, and Strategic Reset
Personal wellness company WeightWatchers (NASDAQ:WW) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 10.5% year on year to $184.4 million. Its non-GAAP profit of $0.32 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
VSTS Q1 Earnings Call: Revenue Miss, Service Challenges, and Leadership Transition Shape Outlook
Uniform rental provider Vestis Corporation (NYSE:VSTS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.7% year on year to $665.2 million. On the other hand, the company expects next quarter’s revenue to be around $678 million, close to analysts’ estimates. Its non-GAAP loss of $0.05 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
KLIC Q1 Earnings Call: Management Restructures Amid Revenue Miss and Macro Uncertainty
Semiconductor production equipment company Kulicke & Soffa (NASDAQ: KLIC) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $162 million. Next quarter’s revenue guidance of $145 million underwhelmed, coming in 0.5% below analysts’ estimates. Its non-GAAP loss of $0.52 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
WOW Q1 Earnings Call: Fiber Expansion and Margin Discipline Amid Revenue Pressure
Broadband and telecommunications services provider WideOpenWest (NYSE:WOW) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 7.1% year on year to $150 million. On the other hand, next quarter’s revenue guidance of $142.5 million was less impressive, coming in 0.7% below analysts’ estimates. Its GAAP loss of $0.17 per share was 11.3% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
AGL Q1 Earnings Call: Membership Declines, Technology Investments, and Cautious Outlook for 2025
Healthcare services company Agilon Health (NYSE:AGL) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 4.5% year on year to $1.53 billion. The company expects next quarter’s revenue to be around $1.47 billion, close to analysts’ estimates. Its non-GAAP profit of $0.03 per share was $0.02 above analysts’ consensus estimates.
Via StockStory · May 19, 2025
UFPT Q1 Earnings Call: Medical Segment Growth and Strategic Expansion Drive Outperformance
Medical products company UFP Technologies (NASDAQ:UFPT) announced better-than-expected revenue in Q1 CY2025, with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of $2.47 per share was 22.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
GLDD Q1 Earnings Call: Outperformance Driven by Project Execution and Backlog Expansion
Dredging and coastal protection company Great Lakes Dredge & Dock (NASDAQ:GLDD) announced better-than-expected revenue in Q1 CY2025, with sales up 22.3% year on year to $242.9 million. Its non-GAAP profit of $0.49 per share was 86.7% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
FSTR Q1 Earnings Call: Rail Weakness Drives Revenue Miss, Management Maintains Bullish Full-Year Outlook
Railway infrastructure company L.B. Foster (NASDAQ:FSTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 21.3% year on year to $97.79 million. On the other hand, the company’s full-year revenue guidance of $560 million at the midpoint came in 3% above analysts’ estimates. Its GAAP loss of $0.20 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
ARRY Q1 Earnings Call: Revenue Beats Expectations, Margin and Cash Flow Pressures Persist
Solar tracking systems manufacturer Array (NASDAQ:ARRY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 97.1% year on year to $302.4 million. The company’s full-year revenue guidance of $1.1 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP loss of $0.01 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
IPGP Q1 Earnings Call: Tariff Headwinds, Product Diversification, and Bookings Momentum
Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 9.6% year on year to $227.8 million. On the other hand, next quarter’s revenue guidance of $225 million was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $0.34 per share was 56.3% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
JJSF Q1 Earnings Call: Theater Weakness, Cost Pressures Shape Results, Company Eyes Recovery
Snack food company J&J Snack Foods (NASDAQ:JJSF) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1% year on year to $356.1 million. Its non-GAAP profit of $0.35 per share was 48.3% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
GBTG Q1 Earnings Call: Revenue Misses Expectations as Management Cuts Full-Year Guidance
B2B travel services company Global Business Travel (NYSE:GBTG) fell short of the market’s revenue expectations in Q1 CY2025 as sales only rose 1.8% year on year to $621 million. On the other hand, the company expects next quarter’s revenue to be around $625 million, close to analysts’ estimates. Its non-GAAP profit of $0.16 per share was 6.6% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
LIND Q1 Earnings Call: Occupancy, Yield Growth, and Strategic Initiatives Drive Outperformance
Cruise and exploration company Lindblad Expeditions (NASDAQ:LIND) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 17% year on year to $179.7 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
ZTS Q1 Earnings Call: Guidance Raised as Platform Products Drive Momentum Amid Competitive Pressures
Animal health company Zoetis (NYSE:ZTS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.4% year on year to $2.22 billion. The company’s full-year revenue guidance of $9.5 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $1.48 per share was 5.8% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
AHCO Q1 Earnings Call: Guidance Trimmed as Diabetes and Sleep Segments Face Mixed Recovery
Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.8% year on year to $777.9 million. On the other hand, the company’s full-year revenue guidance of $3.25 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
SEE Q1 Earnings Call: Tariffs, Transformation, and Segment Realignment Shape Outlook
Integrated packaging solutions provider Sealed Air Corporation (NYSE:SEE) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.3% year on year to $1.27 billion. The company expects the full year’s revenue to be around $5.3 billion, close to analysts’ estimates. Its non-GAAP profit of $0.81 per share was 20.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MAR Q1 Earnings Call: Revenue Beats Expectations Amid Cautious U.S. Outlook and Growth in International Segments
Global hospitality company Marriott (NASDAQ:MAR) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 4.8% year on year to $6.26 billion. Its non-GAAP profit of $2.32 per share was 3.1% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
SHLS Q1 Earnings Call: Revenue Beat Expectations Amid Margin Pressure, Outlook Supported by Backlog
Solar energy systems company Shoals (NASDAQ:SHLS) announced better-than-expected revenue in Q1 CY2025, but sales fell by 11.5% year on year to $80.36 million. Guidance for next quarter’s revenue was better than expected at $105 million at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
NOVT Q1 Earnings Call: Resilient Performance Amid Trade Headwinds and Strategic Acquisition
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next quarter’s revenue guidance of $235 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.74 per share was 9.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
EVGO Q1 Earnings Call: Utilization, Efficiency, and Strategic Expansion Drive Results
Electric vehicle charging company EVgo (NASDAQ:EVGO) announced better-than-expected revenue in Q1 CY2025, with sales up 36.5% year on year to $75.29 million. The company’s full-year revenue guidance of $360 million at the midpoint came in 2.3% above analysts’ estimates. Its non-GAAP loss of $0.08 per share was 30.8% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty
Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $2.70 per share was 2.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
DOCN Q1 Earnings Call: Large Enterprise Momentum and AI Investments Drive Results
Cloud computing provider DigitalOcean (NYSE: DOCN) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 14.1% year on year to $210.7 million. The company expects next quarter’s revenue to be around $216.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.56 per share was 25.8% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
THS Q1 Earnings Call: Margin Initiatives Offset Volume Declines as TreeHouse Foods Reconfirms 2025 Guidance
Private label food company TreeHouse Foods (NYSE:THS) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.6% year on year to $792 million. The company expects next quarter’s revenue to be around $792.5 million, coming in 0.5% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
KTB Q1 Earnings Call: Helly Hansen Acquisition and Margin Initiatives Dominate Outlook
Clothing company Kontoor Brands (NYSE:KTB) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.3% year on year to $622.9 million. The company’s full-year revenue guidance of $3.08 billion at the midpoint came in 16.7% above analysts’ estimates. Its non-GAAP profit of $1.20 per share was 3.1% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
ENR Q1 Earnings Call: Tariff Risks and Cautious Consumer Outlook Temper Guidance
Battery and lighting company Energizer (NYSE:ENR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $662.9 million. Next quarter’s revenue guidance of $694.4 million underwhelmed, coming in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.67 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
VPG Q1 Earnings Call: Management Cites Order Recovery Amid Revenue Miss and Cautious Outlook
Precision measurement and sensing technologies provider Vishay Precision (NYSE:VPG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $71.74 million. Next quarter’s revenue guidance of $73 million underwhelmed, coming in 3.6% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was 42.9% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
PINC Q1 Earnings Call: Revenue Tops Estimates Amid Tariff and Margin Pressures
Healthcare tech company Premier (NASDAQ:PINC) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 8.9% year on year to $261.4 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.44 per share was 45% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
OMCL Q1 Earnings Call: Revenue Tops Expectations but Tariff Headwinds Pressure Profit Outlook
Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s revenue guidance of $275 million was less impressive, coming in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.26 per share was 27.1% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
NPO Q1 Earnings Call: Margin Expansion and End Market Diversification Support 2025 Outlook
Industrial technology solutions provider EnPro Industries (NYSE:NPO) announced better-than-expected revenue in Q1 CY2025, with sales up 6.1% year on year to $273.2 million. On the other hand, the company’s full-year revenue guidance of $0.04 at the midpoint came in 100% below analysts’ estimates. Its non-GAAP profit of $1.90 per share was 14% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
ATKR Q1 Earnings Call: Tariffs and Data Center Demand Shape Outlook Amid Volume Recovery
Electrical safety company Atkore (NYSE:ATKR) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 11.5% year on year to $701.7 million. Its non-GAAP profit of $2.04 per share was 19.2% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MD Q1 Earnings Call: Cost Discipline, Portfolio Restructuring Drive Outperformance Amid Industry Uncertainty
Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 7.4% year on year to $458.4 million. Its non-GAAP profit of $0.33 per share was 38.3% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
KBR Q1 Earnings Call: Revenue Misses, Strong Profitability, and Guidance Reaffirmed
Government and sustainable technology solutions company KBR (NYSE:KBR) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 13% year on year to $2.06 billion. On the other hand, the company’s full-year revenue guidance of $8.9 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $0.98 per share was 13.7% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
WAT Q1 Earnings Call: Instrument Demand and Targeted Pricing Drive Outperformance; Guidance Raised Amid Tariff Mitigation
Scientific instruments company Waters Corporation (NYSE:WAT) announced better-than-expected revenue in Q1 CY2025, with sales up 3.9% year on year to $661.7 million. Guidance for next quarter’s revenue was better than expected at $751 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.25 per share was 1.2% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
BALL Q1 Earnings Call: Outperformance Driven by Global Volume Growth and Operational Efficiency
Packaging manufacturer Ball (NYSE:BLL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.8% year on year to $3.1 billion. Its non-GAAP profit of $0.76 per share was 8.4% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
DCO Q1 Earnings Call: Defense Growth Offsets Commercial Aerospace Weakness, Margin Expansion Continues
Aerospace and defense company Ducommun (NYSE:DCO) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 1.7% year on year to $194.1 million. Its non-GAAP profit of $0.83 per share was 18.5% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MWA Q1 Earnings Call: Pricing Actions, Tariff Impacts, and Operational Shifts Drive Outlook
Water infrastructure products manufacturer Mueller Water Products reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 3.1% year on year to $364.3 million. The company’s full-year revenue guidance of $1.4 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.34 per share was 10% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
ACEL Q1 Earnings Call: Local Market Growth, New Racino Launch, and CFO Transition Highlight Quarter
Slot machine and terminal operator Accel Entertainment (NYSE:ACEL) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 7.3% year on year to $323.9 million. Its non-GAAP profit of $0.23 per share was 17.8% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
JELD Q1 Earnings Call: Revenue Beats Expectations Amid Market and Tariff Headwinds
Building products manufacturer JELD-WEN (NYSE:JELD) announced better-than-expected revenue in Q1 CY2025, but sales fell by 19.1% year on year to $776 million. Its non-GAAP loss of $0.17 per share was 11.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
BFAM Q1 Earnings Call: Enrollment Gains and Margin Expansion Amid Mixed Demand Signals
Child care and education company Bright Horizons (NYSE:BFAM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.9% year on year to $665.5 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $2.89 billion at the midpoint. Its non-GAAP profit of $0.77 per share was 19.8% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
PRIM Q1 Earnings Call: Utilities and Renewables Segments Drive Outperformance Amid Ongoing Policy Uncertainty
Infrastructure construction company Primoris (NYSE:PRIM) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 16.7% year on year to $1.65 billion. Its non-GAAP profit of $0.98 per share was 49.2% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
IPAR Q1 Earnings Call: Brand Mix and Supply Chain Flexibility Offset Tariff Concerns
Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.6% year on year to $338.8 million. The company expects the full year’s revenue to be around $1.51 billion, close to analysts’ estimates. Its GAAP profit of $1.32 per share was 18.1% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MYPS Q1 Earnings Call: PLAYSTUDIOS Targets Sweepstakes Entry Amid Ongoing User Declines
Digital casino game platform PlayStudios (NASDAQ:MYPS) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 19.4% year on year to $62.71 million. On the other hand, the company’s full-year revenue guidance of $260 million at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.02 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
RRX Q1 Earnings Call: Tariff Mitigation and Automation Momentum Drive Guidance Reaffirmation
Industrials products and automation company Regal Rexnord (NYSE:RRX). reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 8.4% year on year to $1.42 billion. Its non-GAAP profit of $2.15 per share was 17.7% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
IAC Q1 Earnings Call: Revenue Misses, Cost Discipline Drives Margin Recovery
Digital media conglomerate IAC (NASDAQGS:IAC) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 8.6% year on year to $570.5 million. Its non-GAAP loss of $2.73 per share was 38.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
BCC Q1 Earnings Call: Revenue Beats, Margins Impacted by Housing Market and Facility Outage
Building products company Boise Cascade Company (NYSE:BCC) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 6.6% year on year to $1.54 billion. Its non-GAAP profit of $1.06 per share was 17.8% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
CLX Q1 Earnings Call: Clorox Cites Category Weakness, Maintains Full-Year Margin Guidance
Consumer products giant Clorox (NYSE:CLX) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 8% year on year to $1.67 billion. Its non-GAAP profit of $1.45 per share was 6.9% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
BWXT Q1 Earnings Call: Strong Revenue Beat and Contract Wins Offset Margin Pressures
Aerospace and defense company BWX (NYSE:BWXT) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 13% year on year to $682.3 million. On the other hand, the company’s full-year revenue guidance of $3 billion at the midpoint came in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.91 per share was 19.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
AL Q1 Earnings Call: Higher Lease Rates and Insurance Recoveries Drive Earnings Beat
Aircraft leasing company Air Lease Corporation (NYSE:AL) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.3% year on year to $738.3 million. Its non-GAAP profit of $2.19 per share was 85.2% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
EVER Q1 Earnings Call: Revenue Growth Outpaces Expectations, Profitability Lags
Online insurance comparison site EverQuote (NASDAQ:EVER) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 83% year on year to $166.6 million. The company expects next quarter’s revenue to be around $157.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.34 per share was 31.5% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
CORT Q1 Earnings Call: Pharmacy Disruptions Overshadow Prescription Growth, Guidance Reaffirmed
Biopharma company Corcept Therapeutics (NASDAQ:CORT) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $157.2 million. On the other hand, the company’s full-year revenue guidance of $925 million at the midpoint came in 2.2% above analysts’ estimates. Its non-GAAP profit of $0.17 per share was 19.3% above analysts’ consensus estimates.
Via StockStory · May 19, 2025